A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...

A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains ...

A new study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains just 8.5 months.

Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the ...

Treatment with bexmarilimab and Vidaza elicited high overall response rates in both frontline and relapsed/refractory ...

Over the years our annual Pathways to Health Symposium has hosted researchers and community champions to discuss important topics related to cancer health disparities ... equity through policy and ...

Potential treatments need to be subject to the highest standards of safety and efficacy. Transplanting dopamine-releasing neurons into the brain is a promising regenerative therapy for Parkinson ...

Trauma-focused cognitive behavioral therapy (TF-CBT) is a type of therapy that can help with acute stress disorder. CBT is a highly evidence-based form of therapy that teaches people how to identify ...

There’s no way to prevent cataracts, but making some lifestyle changes might lower your odds of them progressing more rapidly.

Chronic myeloid (or myelogenous) leukaemia (CML), also known as chronic granulocytic leukaemia, is a cancer of the white blood cells. It is characterized by the increased and unregulated growth of ...